{"basic_info": {"ticker": "300529", "exchange": "XSHE", "bloomberg_ticker": "300529 CH Equity", "name": "JAFRON BIOMEDICAL CO LTD-A", "industry": "Health Care Equipment & Supplies", "name_chinese_simplified": "健帆生物", "period": "2020", "market_value": 55234424832, "total_income": 1950780490, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 1729679932, "business_income_over_total_income": 0.8866604627566272}, {"shariah_compliance": "unknown", "income": 221100558, "business_income_over_total_income": 0.11333953724337278}], "details": [{"business_activity_cn": "一次性使用血液灌流器", "business_activity_en": "One-time use of blood perfusion", "income": 1729679932, "business_income_over_total_income": 0.8866604627566272, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 221100558, "business_income_over_total_income": 0.11333953724337278, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.00020776415520616916, "shariah_compliance": "compliant", "amount_over_market_value": 0.00020776415520616916}]}